GSK Executive's Strategic Share Transfer Signals Confidence in Long-term Holdings

Rhea-AI Filing Summary

GSK has reported multiple share transactions by Sally Jackson, SVP of Global Communications & CEO Office, and her associated person Dylan Jackson on June 19, 2025. The transactions include:

• Sally Jackson gifted 1,400 ordinary shares to a family member at nil consideration
• Sally Jackson sold 1,395 shares at £14.3524 and purchased 1,387 shares at £14.3378 as part of an ISA transfer
• Dylan Jackson (PCA) sold 1,395 shares at £14.3524 and purchased 1,385 shares at £14.3537 as part of an ISA transfer

All transactions were conducted on the London Stock Exchange. These share movements represent portfolio restructuring into Individual Savings Accounts (ISAs) rather than significant changes in ownership positions. The transactions were reported in compliance with regulatory requirements for PDMRs (Persons Discharging Managerial Responsibilities) and their closely associated persons.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sally Jackson
b)	Position/status	SVP, Global Communications & CEO Office
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	Gift of ordinary shares to family member for nil consideration
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£0.00	1,400
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2025-06-19
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sally Jackson
b)	Position/status	SVP, Global Communications & CEO Office
c)	Initial notification/amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary Shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	The sale of 1,395 Ordinary Shares to facilitate a transfer into an ISA
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£14.3524	1,395
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2025-06-19
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sally Jackson
b)	Position/status	SVP, Global Communications & CEO Office
c)	Initial notification/amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary Shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	The purchase of 1,387 Ordinary Shares into an ISA
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£14.3378	1,387
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2025-06-19
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Dylan Jackson
b)	Position/status	PCA of Sally Jackson (SVP, Global Communications & CEO Office)
c)	Initial notification/amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary Shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	The sale of 1,395 Ordinary Shares to facilitate a transfer into an ISA
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£14.3524	1,395
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2025-06-19
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Dylan Jackson
b)	Position/status	PCA of Sally Jackson (SVP, Global Communications & CEO Office)
c)	Initial notification/amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary Shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	The purchase of 1,385 Ordinary Shares into an ISA
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£14.3537	1,385
		d)	Aggregated information	N/A (single transaction)
Aggregated volume   Price
e)	Date of the transaction	2025-06-19
f)	Place of the transaction	London Stock Exchange (XLON)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: June 24, 2025

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc

FAQ

What insider transactions did GSK's SVP Sally Jackson report in June 2025?

Sally Jackson, SVP of Global Communications & CEO Office, reported multiple transactions on June 19, 2025: 1) A gift of 1,400 ordinary shares to a family member, 2) Sale of 1,395 shares at £14.3524 per share, and 3) Purchase of 1,387 shares at £14.3378 per share into an ISA (Individual Savings Account).

What was the share price of GSK stock during the reported transactions on June 19, 2025?

GSK shares traded between £14.3378 and £14.3537 per share during the reported transactions on June 19, 2025, with most transactions occurring around the £14.35 price level on the London Stock Exchange.

Who is Dylan Jackson in relation to GSK's insider trading report?

Dylan Jackson is identified as a PCA (Person Closely Associated) with Sally Jackson, who is GSK's SVP of Global Communications & CEO Office. Dylan Jackson conducted similar share transactions, selling 1,395 shares at £14.3524 and buying 1,385 shares at £14.3537 into an ISA.

What type of shares were traded in GSK's June 2025 insider transactions?

The transactions involved GSK plc Ordinary Shares of 31¼ pence each, trading under ISIN: GB00BN7SWP63 on the London Stock Exchange (XLON).

Why did GSK insiders transfer shares to ISAs in June 2025?

The filing shows both Sally Jackson and Dylan Jackson sold and repurchased similar amounts of shares specifically 'to facilitate a transfer into an ISA' (Individual Savings Account), which is a tax-efficient investment account in the UK.